Drug monitoring methods using the promyelocytic leukemia protein as a redox sensor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9228998
APP PUB NO 20140205568A1
SERIAL NO

14200436

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a method for determining the redox status of a cell or tissue comprising a step consisting of determining the level of PML nuclear bodies in said cell or tissue.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE;UNIVERSITE PARIS DIDEROT—PARIS 7

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
De, The Hugues Paris, FR 7 2
Lallemand-Breitenbach, Valerie Paris, FR 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 5, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00